Skip to main content
Top
Published in: Journal of Cancer Education 1/2012

01-03-2012

“The Promise of Community-Based Advocacy and Education Efforts for Increasing Cancer Clinical Trials Accrual”

Authors: Margo Michaels, Elisa S. Weiss, John A. Guidry, Natasha Blakeney, Liz Swords, Brian Gibbs, Samantha Yeun, Bruce Rytkonen, Robert Goodman, S. Lisbeth Jarama, Amanda L. Greene, Shilpa Patel

Published in: Journal of Cancer Education | Issue 1/2012

Login to get access

Abstract

Only 3% of cancer patients participate in cancer clinical trials (CCTs). A number of barriers to participation, particularly for minority groups, can be addressed through community-focused education and advocacy efforts. Working with community partnerships, a pilot program sought to change knowledge, attitudes, and role behaviors among community leaders, primary care providers (PCPs), and clinical researchers about CCTs, to increase patient awareness of and participation in CCTs. A mixed method evaluation utilized quantitative analysis of surveys administered to participants during the program period (2006–2008) and qualitative data from interviews with key participants. Programmatic efforts were effective in increasing knowledge and training community leaders and PCPs to disseminate messages about clinical trials, and ultimately increasing patient inquiries about local trials. Training improved cultural competency skills among clinical researchers to recruit and retain CCT participants. Partnerships fostered new processes and structures to facilitate CCT participation in their communities. Clinical trials education and advocacy efforts through community partnerships have an important role in enhancing clinical trial access and in increasing clinical trial participation. Oncologists’ involvement in and leadership of such partnerships are critical to promoting CCT accrual, particularly for minority groups.
Literature
3.
go back to reference Murthy VH, Krumholz HM et al (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291(22):2720–2726PubMedCrossRef Murthy VH, Krumholz HM et al (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291(22):2720–2726PubMedCrossRef
4.
go back to reference Nass SJ, Moses HL, Mendelsohn J. (eds) (2010) National Cancer Clinical Trials System for the 21st Century: reinvigorating the NCI Cooperative Group Program. Committee on Cancer Clinical Trials and the NCI Cooperative Group Program. Institute of Medicine of the National Academies Nass SJ, Moses HL, Mendelsohn J. (eds) (2010) National Cancer Clinical Trials System for the 21st Century: reinvigorating the NCI Cooperative Group Program. Committee on Cancer Clinical Trials and the NCI Cooperative Group Program. Institute of Medicine of the National Academies
5.
go back to reference Mills EJ, Seely D et al (2006) Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol 7(2):141–148PubMedCrossRef Mills EJ, Seely D et al (2006) Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patient-reported factors. Lancet Oncol 7(2):141–148PubMedCrossRef
6.
go back to reference Markman M, Petersen J et al (2008) An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials. J Cancer Res Clin Oncol 134(1):115–118PubMedCrossRef Markman M, Petersen J et al (2008) An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials. J Cancer Res Clin Oncol 134(1):115–118PubMedCrossRef
7.
go back to reference Jones JM, Nyhof-Young J et al (2006) Identifying motivations and barriers to patient participation in clinical trials. J Cancer Educ 21(4):237–242PubMedCrossRef Jones JM, Nyhof-Young J et al (2006) Identifying motivations and barriers to patient participation in clinical trials. J Cancer Educ 21(4):237–242PubMedCrossRef
8.
go back to reference Corbie-Smith G, Thomas SB et al (2002) Distrust, race, and research. Arch Intern Med 162(21):2458–2463PubMedCrossRef Corbie-Smith G, Thomas SB et al (2002) Distrust, race, and research. Arch Intern Med 162(21):2458–2463PubMedCrossRef
9.
go back to reference Ford JG, Howerton MW et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242PubMedCrossRef Ford JG, Howerton MW et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228–242PubMedCrossRef
10.
go back to reference Comis RL, Miller JD et al (2009) Physician-related factors involved in patient decisions to enroll onto cancer clinical trials. J Oncol Pract 5(2):50–56PubMedCrossRef Comis RL, Miller JD et al (2009) Physician-related factors involved in patient decisions to enroll onto cancer clinical trials. J Oncol Pract 5(2):50–56PubMedCrossRef
11.
go back to reference Ford JG, Howerton MW et al. (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials (evidence report/technology assessment no. 122). Baltimore (MD): Johns Hopkins University, Evidence-based Practice Center; AHRQ Publication No. 05-E019-2; Contract No. 290-02-0018 Ford JG, Howerton MW et al. (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials (evidence report/technology assessment no. 122). Baltimore (MD): Johns Hopkins University, Evidence-based Practice Center; AHRQ Publication No. 05-E019-2; Contract No. 290-02-0018
12.
go back to reference Weinberg AD, Cooper HP et al (2004) Attitudes of primary care physicians and specialists about cancer clinical trials: a survey of Texas physicians. Tex Med 100(4):66–72PubMed Weinberg AD, Cooper HP et al (2004) Attitudes of primary care physicians and specialists about cancer clinical trials: a survey of Texas physicians. Tex Med 100(4):66–72PubMed
13.
go back to reference Crosson K, Eisner E et al (2001) Primary care physicians’ attitudes, knowledge and practices related to cancer clinical trials. J Cancer Educ 16(4):188–192PubMed Crosson K, Eisner E et al (2001) Primary care physicians’ attitudes, knowledge and practices related to cancer clinical trials. J Cancer Educ 16(4):188–192PubMed
14.
go back to reference Sherwood PR, Given BA et al (2004) To refer or not to refer: factors that affect primary care provider referral of patients with cancer to clinical treatment trials. J Cancer Educ 19(1):58–65PubMedCrossRef Sherwood PR, Given BA et al (2004) To refer or not to refer: factors that affect primary care provider referral of patients with cancer to clinical treatment trials. J Cancer Educ 19(1):58–65PubMedCrossRef
15.
go back to reference Chen DT, Miller FG, Rosenstein DL (2003) Clinical research and the physician-patient relationship. Ann Intern Med 138(8):669–672PubMed Chen DT, Miller FG, Rosenstein DL (2003) Clinical research and the physician-patient relationship. Ann Intern Med 138(8):669–672PubMed
16.
go back to reference Howerton MW, Gibbons MC et al (2007) Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer 109(3):465–476PubMedCrossRef Howerton MW, Gibbons MC et al (2007) Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer 109(3):465–476PubMedCrossRef
17.
go back to reference Sateren WB et al (2002) How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20(8):2109–2117 Sateren WB et al (2002) How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20(8):2109–2117
18.
go back to reference Brown RF, Butow PN et al (2007) Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills training. Psychooncology 16(6):507–516PubMedCrossRef Brown RF, Butow PN et al (2007) Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills training. Psychooncology 16(6):507–516PubMedCrossRef
19.
go back to reference Albrecht TL, Blanchard C et al (2008) Influence of clinical communication on patients’ decision making on participation in clinical trials. J Clin Oncol 26(16):2666–2673PubMedCrossRef Albrecht TL, Blanchard C et al (2008) Influence of clinical communication on patients’ decision making on participation in clinical trials. J Clin Oncol 26(16):2666–2673PubMedCrossRef
20.
go back to reference Joseph G, Dohan D (2009) Diversity of participants in clinical trials in an academic medical center: the role of the ‘good study patient?’. Cancer 115(3):608–615, 1PubMedCrossRef Joseph G, Dohan D (2009) Diversity of participants in clinical trials in an academic medical center: the role of the ‘good study patient?’. Cancer 115(3):608–615, 1PubMedCrossRef
21.
go back to reference Jenkins V, Fallowfield L et al (2005) Discussing randomized clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme. BMJ 330(7488):400PubMedCrossRef Jenkins V, Fallowfield L et al (2005) Discussing randomized clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme. BMJ 330(7488):400PubMedCrossRef
22.
go back to reference Paskett ED, Cooper MR et al (2002) Clinical trial enrollment of rural patients with cancer. Cancer Pract 10(1):28–35 Paskett ED, Cooper MR et al (2002) Clinical trial enrollment of rural patients with cancer. Cancer Pract 10(1):28–35
23.
go back to reference Wendler D, Kington R et al (2006) Are racial and ethnic minorities less willing to participate in health research? PLoS Med 3(2):e19, Epub 2005PubMedCrossRef Wendler D, Kington R et al (2006) Are racial and ethnic minorities less willing to participate in health research? PLoS Med 3(2):e19, Epub 2005PubMedCrossRef
24.
go back to reference Rogers EM (2003) Diffusion of innovations, 5th edn. Free Press, New York Rogers EM (2003) Diffusion of innovations, 5th edn. Free Press, New York
25.
go back to reference Kelly JA, St Lawrence JS et al (1991) HIV risk behavior reduction following intervention with key opinion leaders of a population: an experimental analysis. Am J Public Health 81(2):168–171PubMedCrossRef Kelly JA, St Lawrence JS et al (1991) HIV risk behavior reduction following intervention with key opinion leaders of a population: an experimental analysis. Am J Public Health 81(2):168–171PubMedCrossRef
26.
go back to reference Kelly JA, St Lawrence JS et al (1992) Community AIDS/HIV risk reduction: the effects of endorsements by popular people in three cities. Am J Public Health 82(11):1483–1489PubMedCrossRef Kelly JA, St Lawrence JS et al (1992) Community AIDS/HIV risk reduction: the effects of endorsements by popular people in three cities. Am J Public Health 82(11):1483–1489PubMedCrossRef
27.
go back to reference Sanson-Fisher RW (2004) Diffusion of innovation theory for clinical change. Med J Aust 180(6 Suppl):S55–S56PubMed Sanson-Fisher RW (2004) Diffusion of innovation theory for clinical change. Med J Aust 180(6 Suppl):S55–S56PubMed
28.
go back to reference Lasker RD, Weiss ES (2003) Creating partnership synergy: the critical role of community stakeholders. J Health Hum Serv Adm 26(1):119–139PubMed Lasker RD, Weiss ES (2003) Creating partnership synergy: the critical role of community stakeholders. J Health Hum Serv Adm 26(1):119–139PubMed
29.
go back to reference Solomon FM, Eberl-Lefko AC, Michaels M et al (2005) Development of a linguistically and culturally appropriate booklet for Latino cancer survivors: lessons learned. Health Promot Pract 6(4):405–413PubMedCrossRef Solomon FM, Eberl-Lefko AC, Michaels M et al (2005) Development of a linguistically and culturally appropriate booklet for Latino cancer survivors: lessons learned. Health Promot Pract 6(4):405–413PubMedCrossRef
30.
go back to reference National Standards for Culturally and Linguistically Appropriate Services in Health Care (2001) U.S. Department of Health and Human Services Office of Minority Health National Standards for Culturally and Linguistically Appropriate Services in Health Care (2001) U.S. Department of Health and Human Services Office of Minority Health
32.
go back to reference Pande PS, Neuman RP et al (2002) The Six Sigma way team fieldbook: an implementation guide for process improvement teams. McGraw-Hill, Columbus Pande PS, Neuman RP et al (2002) The Six Sigma way team fieldbook: an implementation guide for process improvement teams. McGraw-Hill, Columbus
33.
go back to reference Seifer SD, Michaels M et al (2010) Applying community-based participatory research principles and approaches in clinical trials: forging a new model for cancer clinical research. Prog Community Health Partnersh 4(1):37–46, SpringPubMedCrossRef Seifer SD, Michaels M et al (2010) Applying community-based participatory research principles and approaches in clinical trials: forging a new model for cancer clinical research. Prog Community Health Partnersh 4(1):37–46, SpringPubMedCrossRef
Metadata
Title
“The Promise of Community-Based Advocacy and Education Efforts for Increasing Cancer Clinical Trials Accrual”
Authors
Margo Michaels
Elisa S. Weiss
John A. Guidry
Natasha Blakeney
Liz Swords
Brian Gibbs
Samantha Yeun
Bruce Rytkonen
Robert Goodman
S. Lisbeth Jarama
Amanda L. Greene
Shilpa Patel
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Journal of Cancer Education / Issue 1/2012
Print ISSN: 0885-8195
Electronic ISSN: 1543-0154
DOI
https://doi.org/10.1007/s13187-011-0271-6

Other articles of this Issue 1/2012

Journal of Cancer Education 1/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine